Merck & Co., Inc: Spondylitis, Ankylosing trials

The registry lists 14 Spondylitis, Ankylosing studies with Merck & Co., Inc as lead sponsor. 0 are open to participants now and 10 have results posted.

Phase 3 3Phase 4 6No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Clinical and Radiological Manifestations of Coxitis in Patients With Ankylosing Spondylitis Treated With GolimumabCompletedNCT03557853Results posted
• The Incidence of Extra-Articular Manifestations in Participants With Ankylosing Spondylitis Treated With Golimumab (MK-8259-012)CompletedNCT01668004Phase 4Results posted
• Effect of Golimumab in Participants With Active Axial Spondyloarthritis (P07642, MK-8259-006)CompletedNCT01453725Phase 3Results posted
• A Study to Investigate the Use of Golimumab (Simponi®) in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554)CompletedNCT01313858Results posted
• Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1)CompletedNCT00844805Phase 3Results posted
• Remicade Safety Line (Ankylosing Spondylitis)(Study P03275)(COMPLETED)CompletedNCT00818168Results posted
• Analysis of the Peripheral Blood Mononuclear Cells of Patients With Ankylosing Spondylitis During Infliximab Treatment (Study P04465)(COMPLETED)CompletedNCT00778869Phase 4Results posted
• Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840)CompletedNCT00727298Results posted
• Investigation of 9 Consecutive Remicade Infusions in Ankylosing Spondylitis in Austria (Study P04044)(COMPLETED)CompletedNCT00725543Results posted
• Enthesitis With Ultra Sonography Doppler in Spondyloarthropathies Treated With Infliximab (Study P04440)TerminatedNCT00686894Phase 4Results posted
• Effectiveness and Safety of Early Treatment With Infliximab for Hip Arthritis Associated With Ankylosing Spondylitis (AS) (P06451)WithdrawnNCT01148901Phase 4
• Growth Factor Concentration to Predict an Ankylosing Spondylitis Patient's Response to Infliximab (Study P04041)(COMPLETED)CompletedNCT00779935Phase 4
• A Study of the Efficacy and Tolerance of Remicade in the Treatment of Active Ankylosing Spondylitis (Study P04042)(COMPLETED)CompletedNCT00779012Phase 4
• Evaluation of Low Dose Infliximab in Ankylosing Spondylitis (Study P04352)CompletedNCT00202865Phase 3